Capastat 1g Injection

    Capastat 1g Injection

    S4
    PDF Leaflet Revision Date: 14 August 2009


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of pulmonary infections caused by resistant Mycobacterium tuberculosis.

    Dosage (summary)

    1 g daily IM for 60-120 days, then 1 g 2-3 times a week.

    Onset of Action / Duration

    Onset: 1-2 hours, Duration: Not specified.

    Special Populations

    • Renal impairment
    • Elderly

    Pregnancy & Breastfeeding

    Use only if benefits outweigh risks; safety not established.

    Key Drug Interactions

    • Streptomycin
    • Amikacin
    • Gentamicin

    Contraindications

    • Hypersensitivity to CAPASTAT

    Common side effects

    • Elevation of serum creatinine
    • Auditory loss
    • Eosinophilia

    Counselling Points

    • Monitor for renal function and electrolytes
    • Audiometry before and during treatment

    Serious warnings

    • Ototoxicity risk
    • Renal function monitoring required
    Important Disclaimer

    The Capastat 1g Injection professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn